nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—ACE—prostate cancer	0.558	1	CbGaD
Ramipril—ACE—urine—prostate cancer	0.00797	0.177	CbGeAlD
Ramipril—SLC15A1—epithelium—prostate cancer	0.00293	0.0652	CbGeAlD
Ramipril—ACE—prostate gland—prostate cancer	0.00286	0.0636	CbGeAlD
Ramipril—SLC15A1—renal system—prostate cancer	0.00272	0.0605	CbGeAlD
Ramipril—SLC15A2—prostate gland—prostate cancer	0.0025	0.0555	CbGeAlD
Ramipril—ACE—seminal vesicle—prostate cancer	0.00242	0.0538	CbGeAlD
Ramipril—BCHE—prostate gland—prostate cancer	0.00211	0.047	CbGeAlD
Ramipril—SLC15A2—seminal vesicle—prostate cancer	0.00211	0.0469	CbGeAlD
Ramipril—ACE—epithelium—prostate cancer	0.0021	0.0467	CbGeAlD
Ramipril—ACE—renal system—prostate cancer	0.00195	0.0433	CbGeAlD
Ramipril—ACE—urethra—prostate cancer	0.00192	0.0426	CbGeAlD
Ramipril—BCHE—seminal vesicle—prostate cancer	0.00179	0.0397	CbGeAlD
Ramipril—SLC15A2—renal system—prostate cancer	0.0017	0.0378	CbGeAlD
Ramipril—SLC15A2—urethra—prostate cancer	0.00167	0.0371	CbGeAlD
Ramipril—ACE—bone marrow—prostate cancer	0.00148	0.0328	CbGeAlD
Ramipril—ACE—testis—prostate cancer	0.00126	0.028	CbGeAlD
Ramipril—SLC15A2—testis—prostate cancer	0.0011	0.0244	CbGeAlD
Ramipril—BCHE—bone marrow—prostate cancer	0.00109	0.0242	CbGeAlD
Ramipril—BCHE—testis—prostate cancer	0.000932	0.0207	CbGeAlD
Ramipril—ACE—lymph node—prostate cancer	0.000914	0.0203	CbGeAlD
Ramipril—SLC15A2—lymph node—prostate cancer	0.000797	0.0177	CbGeAlD
Ramipril—Fosinopril—ACE—prostate cancer	0.000722	0.111	CrCbGaD
Ramipril—BCHE—lymph node—prostate cancer	0.000675	0.015	CbGeAlD
Ramipril—Perindopril—ACE—prostate cancer	0.000589	0.0909	CrCbGaD
Ramipril—Spirapril—ACE—prostate cancer	0.000582	0.0898	CrCbGaD
Ramipril—Moexipril—ACE—prostate cancer	0.000558	0.0861	CrCbGaD
Ramipril—Benazepril—MTHFR—prostate cancer	0.000554	0.0855	CrCbGaD
Ramipril—Lisinopril—ACE—prostate cancer	0.000519	0.0801	CrCbGaD
Ramipril—Cilazapril—ACE—prostate cancer	0.000519	0.0801	CrCbGaD
Ramipril—Quinapril—ACE—prostate cancer	0.000519	0.0801	CrCbGaD
Ramipril—Trandolapril—ACE—prostate cancer	0.000502	0.0776	CrCbGaD
Ramipril—Benazepril—ACE—prostate cancer	0.000451	0.0697	CrCbGaD
Ramipril—Enalapril—ACE—prostate cancer	0.000381	0.0588	CrCbGaD
Ramipril—Nateglinide—CYP3A5—prostate cancer	0.000282	0.0435	CrCbGaD
Ramipril—Enalapril—CYP3A4—prostate cancer	0.000179	0.0276	CrCbGaD
Ramipril—BCHE—Metabolism of proteins—SSR2—prostate cancer	0.00014	0.00245	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—GALNT3—prostate cancer	0.00014	0.00245	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000138	0.00241	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000138	0.00241	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—RPL10—prostate cancer	0.000136	0.00239	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000135	0.00237	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000131	0.0023	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000131	0.00229	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.00013	0.00227	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—SPON2—prostate cancer	0.000128	0.00224	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—HERPUD1—prostate cancer	0.000128	0.00224	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000128	0.00224	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000128	0.00224	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—LEP—prostate cancer	0.000125	0.00219	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.000123	0.00215	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.000123	0.00215	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.000123	0.00215	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—ATF3—prostate cancer	0.000122	0.00214	CbGpPWpGaD
Ramipril—Nateglinide—CYP3A4—prostate cancer	0.000122	0.0188	CrCbGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000121	0.00212	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00012	0.00211	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—KLK3—prostate cancer	0.000119	0.00208	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.000117	0.00205	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000115	0.00202	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—IGFBP3—prostate cancer	0.000115	0.00202	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—PLCB2—prostate cancer	0.000114	0.002	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—ACHE—prostate cancer	0.000112	0.00197	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—KLK2—prostate cancer	0.000112	0.00196	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—RPN2—prostate cancer	0.000112	0.00196	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MBTPS1—prostate cancer	0.000112	0.00196	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000112	0.00195	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—SLC22A1—prostate cancer	0.000109	0.00191	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—RPS19—prostate cancer	0.000108	0.00189	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—INS—prostate cancer	0.000107	0.00187	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CTSD—prostate cancer	0.000106	0.00186	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—TCP1—prostate cancer	0.000106	0.00186	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—THBS1—prostate cancer	0.000105	0.00183	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.000104	0.00183	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000104	0.00181	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—GNG5—prostate cancer	0.000104	0.00181	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—IGF1—prostate cancer	0.000103	0.00181	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000103	0.0018	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—DNAJC3—prostate cancer	0.000101	0.00177	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CALR—prostate cancer	9.96e-05	0.00174	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	9.82e-05	0.00172	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—GCNT1—prostate cancer	9.71e-05	0.0017	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	9.57e-05	0.00167	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	9.56e-05	0.00167	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—PDIA3—prostate cancer	9.35e-05	0.00164	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	9.31e-05	0.00163	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—ACHE—prostate cancer	9.23e-05	0.00162	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	9.1e-05	0.00159	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—B4GALT4—prostate cancer	9.03e-05	0.00158	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—TPP1—prostate cancer	9.03e-05	0.00158	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—EIF3H—prostate cancer	9.03e-05	0.00158	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	8.88e-05	0.00155	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	8.88e-05	0.00155	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—PRKACB—prostate cancer	8.83e-05	0.00155	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—F9—prostate cancer	8.74e-05	0.00153	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	8.66e-05	0.00152	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—PLAUR—prostate cancer	8.52e-05	0.00149	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	8.45e-05	0.00148	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—COMT—prostate cancer	8.39e-05	0.00147	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MUC4—prostate cancer	8.26e-05	0.00145	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HAO1—prostate cancer	8.1e-05	0.00142	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	8.04e-05	0.00141	CbGpPWpGaD
Ramipril—Hyperhidrosis—Capecitabine—prostate cancer	7.72e-05	0.000232	CcSEcCtD
Ramipril—Oedema peripheral—Epirubicin—prostate cancer	7.71e-05	0.000232	CcSEcCtD
Ramipril—Hypotension—Docetaxel—prostate cancer	7.71e-05	0.000231	CcSEcCtD
Ramipril—Connective tissue disorder—Epirubicin—prostate cancer	7.69e-05	0.000231	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—CTNNB1—prostate cancer	7.68e-05	0.00134	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PIK3CG—prostate cancer	7.67e-05	0.00134	CbGpPWpGaD
Ramipril—Loss of consciousness—Prednisone—prostate cancer	7.66e-05	0.00023	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—prostate cancer	7.63e-05	0.000229	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—prostate cancer	7.61e-05	0.000229	CcSEcCtD
Ramipril—Anorexia—Capecitabine—prostate cancer	7.61e-05	0.000229	CcSEcCtD
Ramipril—Nausea—Estradiol—prostate cancer	7.6e-05	0.000228	CcSEcCtD
Ramipril—Vomiting—Mitoxantrone—prostate cancer	7.58e-05	0.000228	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—prostate cancer	7.57e-05	0.000227	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	7.55e-05	0.00132	CbGpPWpGaD
Ramipril—Convulsion—Prednisone—prostate cancer	7.55e-05	0.000227	CcSEcCtD
Ramipril—Visual impairment—Epirubicin—prostate cancer	7.54e-05	0.000227	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—prostate cancer	7.53e-05	0.000226	CcSEcCtD
Ramipril—Rash—Mitoxantrone—prostate cancer	7.52e-05	0.000226	CcSEcCtD
Ramipril—Dermatitis—Mitoxantrone—prostate cancer	7.51e-05	0.000226	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.51e-05	0.000226	CcSEcCtD
Ramipril—Headache—Mitoxantrone—prostate cancer	7.47e-05	0.000224	CcSEcCtD
Ramipril—Hypotension—Capecitabine—prostate cancer	7.46e-05	0.000224	CcSEcCtD
Ramipril—Insomnia—Docetaxel—prostate cancer	7.46e-05	0.000224	CcSEcCtD
Ramipril—Arthralgia—Prednisone—prostate cancer	7.42e-05	0.000223	CcSEcCtD
Ramipril—Myalgia—Prednisone—prostate cancer	7.42e-05	0.000223	CcSEcCtD
Ramipril—Paraesthesia—Docetaxel—prostate cancer	7.4e-05	0.000222	CcSEcCtD
Ramipril—Erythema multiforme—Epirubicin—prostate cancer	7.4e-05	0.000222	CcSEcCtD
Ramipril—Anxiety—Prednisone—prostate cancer	7.39e-05	0.000222	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.38e-05	0.00129	CbGpPWpGaD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	7.37e-05	0.000221	CcSEcCtD
Ramipril—Dyspnoea—Docetaxel—prostate cancer	7.35e-05	0.000221	CcSEcCtD
Ramipril—Somnolence—Docetaxel—prostate cancer	7.33e-05	0.00022	CcSEcCtD
Ramipril—Discomfort—Prednisone—prostate cancer	7.33e-05	0.00022	CcSEcCtD
Ramipril—Hypersensitivity—Etoposide—prostate cancer	7.31e-05	0.00022	CcSEcCtD
Ramipril—Tinnitus—Epirubicin—prostate cancer	7.3e-05	0.000219	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.27e-05	0.000218	CcSEcCtD
Ramipril—Flushing—Epirubicin—prostate cancer	7.27e-05	0.000218	CcSEcCtD
Ramipril—Dyspepsia—Docetaxel—prostate cancer	7.26e-05	0.000218	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—prostate cancer	7.24e-05	0.000218	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	7.24e-05	0.00127	CbGpPWpGaD
Ramipril—Insomnia—Capecitabine—prostate cancer	7.22e-05	0.000217	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—RPL12—prostate cancer	7.22e-05	0.00126	CbGpPWpGaD
Ramipril—Paraesthesia—Capecitabine—prostate cancer	7.17e-05	0.000215	CcSEcCtD
Ramipril—Decreased appetite—Docetaxel—prostate cancer	7.17e-05	0.000215	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—prostate cancer	7.14e-05	0.000214	CcSEcCtD
Ramipril—Gastrointestinal disorder—Docetaxel—prostate cancer	7.12e-05	0.000214	CcSEcCtD
Ramipril—Asthenia—Etoposide—prostate cancer	7.12e-05	0.000214	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—prostate cancer	7.12e-05	0.000214	CcSEcCtD
Ramipril—Dyspnoea—Capecitabine—prostate cancer	7.12e-05	0.000214	CcSEcCtD
Ramipril—Oedema—Prednisone—prostate cancer	7.11e-05	0.000214	CcSEcCtD
Ramipril—Anaphylactic shock—Prednisone—prostate cancer	7.11e-05	0.000214	CcSEcCtD
Ramipril—Fatigue—Docetaxel—prostate cancer	7.11e-05	0.000214	CcSEcCtD
Ramipril—Nausea—Mitoxantrone—prostate cancer	7.09e-05	0.000213	CcSEcCtD
Ramipril—Immune system disorder—Epirubicin—prostate cancer	7.07e-05	0.000212	CcSEcCtD
Ramipril—Mediastinal disorder—Epirubicin—prostate cancer	7.06e-05	0.000212	CcSEcCtD
Ramipril—Constipation—Docetaxel—prostate cancer	7.05e-05	0.000212	CcSEcCtD
Ramipril—Dyspepsia—Capecitabine—prostate cancer	7.03e-05	0.000211	CcSEcCtD
Ramipril—Pruritus—Etoposide—prostate cancer	7.02e-05	0.000211	CcSEcCtD
Ramipril—Shock—Prednisone—prostate cancer	7e-05	0.00021	CcSEcCtD
Ramipril—Arrhythmia—Epirubicin—prostate cancer	6.99e-05	0.00021	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—prostate cancer	6.98e-05	0.00021	CcSEcCtD
Ramipril—Nervous system disorder—Prednisone—prostate cancer	6.97e-05	0.000209	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	6.97e-05	0.00122	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	6.96e-05	0.00122	CbGpPWpGaD
Ramipril—Tachycardia—Prednisone—prostate cancer	6.94e-05	0.000208	CcSEcCtD
Ramipril—Decreased appetite—Capecitabine—prostate cancer	6.94e-05	0.000208	CcSEcCtD
Ramipril—Alopecia—Epirubicin—prostate cancer	6.92e-05	0.000208	CcSEcCtD
Ramipril—Skin disorder—Prednisone—prostate cancer	6.91e-05	0.000207	CcSEcCtD
Ramipril—Gastrointestinal disorder—Capecitabine—prostate cancer	6.89e-05	0.000207	CcSEcCtD
Ramipril—Fatigue—Capecitabine—prostate cancer	6.88e-05	0.000207	CcSEcCtD
Ramipril—Hyperhidrosis—Prednisone—prostate cancer	6.87e-05	0.000207	CcSEcCtD
Ramipril—Mental disorder—Epirubicin—prostate cancer	6.86e-05	0.000206	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.85e-05	0.0012	CbGpPWpGaD
Ramipril—Erythema multiforme—Doxorubicin—prostate cancer	6.85e-05	0.000206	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—HSP90B1—prostate cancer	6.84e-05	0.0012	CbGpPWpGaD
Ramipril—Constipation—Capecitabine—prostate cancer	6.83e-05	0.000205	CcSEcCtD
Ramipril—Erythema—Epirubicin—prostate cancer	6.81e-05	0.000205	CcSEcCtD
Ramipril—Malnutrition—Epirubicin—prostate cancer	6.81e-05	0.000205	CcSEcCtD
Ramipril—Feeling abnormal—Docetaxel—prostate cancer	6.79e-05	0.000204	CcSEcCtD
Ramipril—Diarrhoea—Etoposide—prostate cancer	6.79e-05	0.000204	CcSEcCtD
Ramipril—Anorexia—Prednisone—prostate cancer	6.78e-05	0.000204	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—prostate cancer	6.75e-05	0.000203	CcSEcCtD
Ramipril—Gastrointestinal pain—Docetaxel—prostate cancer	6.74e-05	0.000203	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—PIK3CD—prostate cancer	6.74e-05	0.00118	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	6.73e-05	0.00118	CbGpPWpGaD
Ramipril—Flushing—Doxorubicin—prostate cancer	6.72e-05	0.000202	CcSEcCtD
Ramipril—Tension—Epirubicin—prostate cancer	6.69e-05	0.000201	CcSEcCtD
Ramipril—Dysgeusia—Epirubicin—prostate cancer	6.67e-05	0.0002	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.64e-05	0.00116	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—EIF3A—prostate cancer	6.63e-05	0.00116	CbGpPWpGaD
Ramipril—Nervousness—Epirubicin—prostate cancer	6.62e-05	0.000199	CcSEcCtD
Ramipril—BCHE—Metabolism—ADI1—prostate cancer	6.6e-05	0.00116	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GRHL1—prostate cancer	6.6e-05	0.00116	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CSAD—prostate cancer	6.6e-05	0.00116	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CBR1—prostate cancer	6.6e-05	0.00116	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PSAT1—prostate cancer	6.6e-05	0.00116	CbGpPWpGaD
Ramipril—BCHE—Metabolism—TST—prostate cancer	6.6e-05	0.00116	CbGpPWpGaD
Ramipril—Feeling abnormal—Capecitabine—prostate cancer	6.58e-05	0.000198	CcSEcCtD
Ramipril—Dizziness—Etoposide—prostate cancer	6.56e-05	0.000197	CcSEcCtD
Ramipril—Muscle spasms—Epirubicin—prostate cancer	6.55e-05	0.000197	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—prostate cancer	6.54e-05	0.000197	CcSEcCtD
Ramipril—Gastrointestinal pain—Capecitabine—prostate cancer	6.53e-05	0.000196	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—prostate cancer	6.53e-05	0.000196	CcSEcCtD
Ramipril—Abdominal pain—Docetaxel—prostate cancer	6.52e-05	0.000196	CcSEcCtD
Ramipril—Body temperature increased—Docetaxel—prostate cancer	6.52e-05	0.000196	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Prednisone—prostate cancer	6.48e-05	0.000195	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—prostate cancer	6.47e-05	0.000194	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	6.46e-05	0.00113	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	6.45e-05	0.00113	CbGpPWpGaD
Ramipril—Insomnia—Prednisone—prostate cancer	6.43e-05	0.000193	CcSEcCtD
Ramipril—BCHE—Neuronal System—COMT—prostate cancer	6.43e-05	0.00113	CbGpPWpGaD
Ramipril—Alopecia—Doxorubicin—prostate cancer	6.4e-05	0.000192	CcSEcCtD
Ramipril—Paraesthesia—Prednisone—prostate cancer	6.39e-05	0.000192	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—prostate cancer	6.35e-05	0.000191	CcSEcCtD
Ramipril—Urticaria—Capecitabine—prostate cancer	6.34e-05	0.000191	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	6.33e-05	0.00111	CbGpPWpGaD
Ramipril—Ill-defined disorder—Epirubicin—prostate cancer	6.32e-05	0.00019	CcSEcCtD
Ramipril—Abdominal pain—Capecitabine—prostate cancer	6.31e-05	0.00019	CcSEcCtD
Ramipril—Body temperature increased—Capecitabine—prostate cancer	6.31e-05	0.00019	CcSEcCtD
Ramipril—Vomiting—Etoposide—prostate cancer	6.31e-05	0.000189	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—prostate cancer	6.31e-05	0.000189	CcSEcCtD
Ramipril—Erythema—Doxorubicin—prostate cancer	6.31e-05	0.000189	CcSEcCtD
Ramipril—Agitation—Epirubicin—prostate cancer	6.26e-05	0.000188	CcSEcCtD
Ramipril—Dyspepsia—Prednisone—prostate cancer	6.26e-05	0.000188	CcSEcCtD
Ramipril—Rash—Etoposide—prostate cancer	6.26e-05	0.000188	CcSEcCtD
Ramipril—Dermatitis—Etoposide—prostate cancer	6.25e-05	0.000188	CcSEcCtD
Ramipril—Headache—Etoposide—prostate cancer	6.22e-05	0.000187	CcSEcCtD
Ramipril—Tension—Doxorubicin—prostate cancer	6.19e-05	0.000186	CcSEcCtD
Ramipril—Decreased appetite—Prednisone—prostate cancer	6.18e-05	0.000186	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—prostate cancer	6.17e-05	0.000185	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.16e-05	0.00108	CbGpPWpGaD
Ramipril—Malaise—Epirubicin—prostate cancer	6.15e-05	0.000185	CcSEcCtD
Ramipril—BCHE—Metabolism—CKMT2—prostate cancer	6.14e-05	0.00107	CbGpPWpGaD
Ramipril—BCHE—Metabolism—UGT2B17—prostate cancer	6.14e-05	0.00107	CbGpPWpGaD
Ramipril—BCHE—Metabolism—UGT2B15—prostate cancer	6.14e-05	0.00107	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GRHPR—prostate cancer	6.14e-05	0.00107	CbGpPWpGaD
Ramipril—Fatigue—Prednisone—prostate cancer	6.13e-05	0.000184	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—prostate cancer	6.12e-05	0.000184	CcSEcCtD
Ramipril—Vertigo—Epirubicin—prostate cancer	6.12e-05	0.000184	CcSEcCtD
Ramipril—Syncope—Epirubicin—prostate cancer	6.11e-05	0.000184	CcSEcCtD
Ramipril—Leukopenia—Epirubicin—prostate cancer	6.1e-05	0.000183	CcSEcCtD
Ramipril—Constipation—Prednisone—prostate cancer	6.08e-05	0.000183	CcSEcCtD
Ramipril—Hypersensitivity—Docetaxel—prostate cancer	6.08e-05	0.000182	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—prostate cancer	6.06e-05	0.000182	CcSEcCtD
Ramipril—Palpitations—Epirubicin—prostate cancer	6.02e-05	0.000181	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	6e-05	0.00105	CbGpPWpGaD
Ramipril—Loss of consciousness—Epirubicin—prostate cancer	5.99e-05	0.00018	CcSEcCtD
Ramipril—Cough—Epirubicin—prostate cancer	5.95e-05	0.000179	CcSEcCtD
Ramipril—Asthenia—Docetaxel—prostate cancer	5.92e-05	0.000178	CcSEcCtD
Ramipril—Convulsion—Epirubicin—prostate cancer	5.9e-05	0.000177	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—MED12—prostate cancer	5.9e-05	0.00103	CbGpPWpGaD
Ramipril—Nausea—Etoposide—prostate cancer	5.89e-05	0.000177	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—LEP—prostate cancer	5.89e-05	0.00103	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MME—prostate cancer	5.88e-05	0.00103	CbGpPWpGaD
Ramipril—Hypersensitivity—Capecitabine—prostate cancer	5.88e-05	0.000177	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—PIK3CB—prostate cancer	5.88e-05	0.00103	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.87e-05	0.00103	CbGpPWpGaD
Ramipril—Feeling abnormal—Prednisone—prostate cancer	5.86e-05	0.000176	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—prostate cancer	5.85e-05	0.000176	CcSEcCtD
Ramipril—Pruritus—Docetaxel—prostate cancer	5.83e-05	0.000175	CcSEcCtD
Ramipril—Gastrointestinal pain—Prednisone—prostate cancer	5.82e-05	0.000175	CcSEcCtD
Ramipril—Chest pain—Epirubicin—prostate cancer	5.8e-05	0.000174	CcSEcCtD
Ramipril—Arthralgia—Epirubicin—prostate cancer	5.8e-05	0.000174	CcSEcCtD
Ramipril—Myalgia—Epirubicin—prostate cancer	5.8e-05	0.000174	CcSEcCtD
Ramipril—Agitation—Doxorubicin—prostate cancer	5.79e-05	0.000174	CcSEcCtD
Ramipril—Anxiety—Epirubicin—prostate cancer	5.78e-05	0.000174	CcSEcCtD
Ramipril—BCHE—Metabolism—SULT2B1—prostate cancer	5.77e-05	0.00101	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MBTPS1—prostate cancer	5.77e-05	0.00101	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTM3—prostate cancer	5.77e-05	0.00101	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NAGLU—prostate cancer	5.77e-05	0.00101	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AOX1—prostate cancer	5.77e-05	0.00101	CbGpPWpGaD
Ramipril—BCHE—Metabolism—RFK—prostate cancer	5.77e-05	0.00101	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PGAM2—prostate cancer	5.77e-05	0.00101	CbGpPWpGaD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.76e-05	0.000173	CcSEcCtD
Ramipril—Discomfort—Epirubicin—prostate cancer	5.73e-05	0.000172	CcSEcCtD
Ramipril—Asthenia—Capecitabine—prostate cancer	5.73e-05	0.000172	CcSEcCtD
Ramipril—Malaise—Doxorubicin—prostate cancer	5.69e-05	0.000171	CcSEcCtD
Ramipril—Dry mouth—Epirubicin—prostate cancer	5.67e-05	0.00017	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—prostate cancer	5.67e-05	0.00017	CcSEcCtD
Ramipril—Syncope—Doxorubicin—prostate cancer	5.65e-05	0.00017	CcSEcCtD
Ramipril—Urticaria—Prednisone—prostate cancer	5.65e-05	0.00017	CcSEcCtD
Ramipril—Pruritus—Capecitabine—prostate cancer	5.65e-05	0.00017	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—prostate cancer	5.64e-05	0.00017	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	5.64e-05	0.000987	CbGpPWpGaD
Ramipril—Diarrhoea—Docetaxel—prostate cancer	5.64e-05	0.000169	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—GRP—prostate cancer	5.63e-05	0.000986	CbGpPWpGaD
Ramipril—Abdominal pain—Prednisone—prostate cancer	5.62e-05	0.000169	CcSEcCtD
Ramipril—Body temperature increased—Prednisone—prostate cancer	5.62e-05	0.000169	CcSEcCtD
Ramipril—Confusional state—Epirubicin—prostate cancer	5.61e-05	0.000168	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	5.58e-05	0.000977	CbGpPWpGaD
Ramipril—Palpitations—Doxorubicin—prostate cancer	5.57e-05	0.000167	CcSEcCtD
Ramipril—Oedema—Epirubicin—prostate cancer	5.56e-05	0.000167	CcSEcCtD
Ramipril—Anaphylactic shock—Epirubicin—prostate cancer	5.56e-05	0.000167	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—prostate cancer	5.54e-05	0.000166	CcSEcCtD
Ramipril—Cough—Doxorubicin—prostate cancer	5.5e-05	0.000165	CcSEcCtD
Ramipril—BCHE—Metabolism—CYP3A43—prostate cancer	5.47e-05	0.000958	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AMACR—prostate cancer	5.47e-05	0.000958	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NAT1—prostate cancer	5.47e-05	0.000958	CbGpPWpGaD
Ramipril—BCHE—Metabolism—DEGS1—prostate cancer	5.47e-05	0.000958	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SRD5A2—prostate cancer	5.47e-05	0.000958	CbGpPWpGaD
Ramipril—Shock—Epirubicin—prostate cancer	5.47e-05	0.000164	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—RPL10—prostate cancer	5.47e-05	0.000957	CbGpPWpGaD
Ramipril—Convulsion—Doxorubicin—prostate cancer	5.46e-05	0.000164	CcSEcCtD
Ramipril—Diarrhoea—Capecitabine—prostate cancer	5.46e-05	0.000164	CcSEcCtD
Ramipril—Nervous system disorder—Epirubicin—prostate cancer	5.45e-05	0.000164	CcSEcCtD
Ramipril—Dizziness—Docetaxel—prostate cancer	5.45e-05	0.000164	CcSEcCtD
Ramipril—Thrombocytopenia—Epirubicin—prostate cancer	5.45e-05	0.000164	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.45e-05	0.000953	CbGpPWpGaD
Ramipril—Tachycardia—Epirubicin—prostate cancer	5.43e-05	0.000163	CcSEcCtD
Ramipril—Skin disorder—Epirubicin—prostate cancer	5.4e-05	0.000162	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	5.38e-05	0.000942	CbGpPWpGaD
Ramipril—Hyperhidrosis—Epirubicin—prostate cancer	5.38e-05	0.000162	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—prostate cancer	5.37e-05	0.000161	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—prostate cancer	5.37e-05	0.000161	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—prostate cancer	5.37e-05	0.000161	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—prostate cancer	5.35e-05	0.000161	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	5.35e-05	0.000936	CbGpPWpGaD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.33e-05	0.00016	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—prostate cancer	5.3e-05	0.000159	CcSEcCtD
Ramipril—Anorexia—Epirubicin—prostate cancer	5.3e-05	0.000159	CcSEcCtD
Ramipril—Dizziness—Capecitabine—prostate cancer	5.28e-05	0.000159	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—prostate cancer	5.25e-05	0.000158	CcSEcCtD
Ramipril—Vomiting—Docetaxel—prostate cancer	5.24e-05	0.000157	CcSEcCtD
Ramipril—Hypersensitivity—Prednisone—prostate cancer	5.24e-05	0.000157	CcSEcCtD
Ramipril—BCHE—Metabolism—HSD17B1—prostate cancer	5.22e-05	0.000914	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	5.22e-05	0.000914	CbGpPWpGaD
Ramipril—Rash—Docetaxel—prostate cancer	5.2e-05	0.000156	CcSEcCtD
Ramipril—Hypotension—Epirubicin—prostate cancer	5.2e-05	0.000156	CcSEcCtD
Ramipril—Dermatitis—Docetaxel—prostate cancer	5.19e-05	0.000156	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—prostate cancer	5.19e-05	0.000156	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	5.18e-05	0.000906	CbGpPWpGaD
Ramipril—Headache—Docetaxel—prostate cancer	5.17e-05	0.000155	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—prostate cancer	5.15e-05	0.000155	CcSEcCtD
Ramipril—Oedema—Doxorubicin—prostate cancer	5.15e-05	0.000155	CcSEcCtD
Ramipril—Asthenia—Prednisone—prostate cancer	5.1e-05	0.000153	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—PTEN—prostate cancer	5.08e-05	0.000889	CbGpPWpGaD
Ramipril—Vomiting—Capecitabine—prostate cancer	5.08e-05	0.000152	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.07e-05	0.000152	CcSEcCtD
Ramipril—Shock—Doxorubicin—prostate cancer	5.06e-05	0.000152	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—prostate cancer	5.05e-05	0.000152	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—prostate cancer	5.04e-05	0.000151	CcSEcCtD
Ramipril—Rash—Capecitabine—prostate cancer	5.03e-05	0.000151	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—INS—prostate cancer	5.03e-05	0.000881	CbGpPWpGaD
Ramipril—Pruritus—Prednisone—prostate cancer	5.03e-05	0.000151	CcSEcCtD
Ramipril—Insomnia—Epirubicin—prostate cancer	5.03e-05	0.000151	CcSEcCtD
Ramipril—Dermatitis—Capecitabine—prostate cancer	5.03e-05	0.000151	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—prostate cancer	5.02e-05	0.000151	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	5.02e-05	0.000879	CbGpPWpGaD
Ramipril—Headache—Capecitabine—prostate cancer	5e-05	0.00015	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—prostate cancer	5e-05	0.00015	CcSEcCtD
Ramipril—Paraesthesia—Epirubicin—prostate cancer	4.99e-05	0.00015	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	4.99e-05	0.000874	CbGpPWpGaD
Ramipril—Hyperhidrosis—Doxorubicin—prostate cancer	4.97e-05	0.000149	CcSEcCtD
Ramipril—Dyspnoea—Epirubicin—prostate cancer	4.96e-05	0.000149	CcSEcCtD
Ramipril—Somnolence—Epirubicin—prostate cancer	4.94e-05	0.000149	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	4.94e-05	0.000865	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ATF3—prostate cancer	4.91e-05	0.000859	CbGpPWpGaD
Ramipril—Anorexia—Doxorubicin—prostate cancer	4.91e-05	0.000147	CcSEcCtD
Ramipril—Nausea—Docetaxel—prostate cancer	4.9e-05	0.000147	CcSEcCtD
Ramipril—Dyspepsia—Epirubicin—prostate cancer	4.9e-05	0.000147	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—IGF1—prostate cancer	4.87e-05	0.000852	CbGpPWpGaD
Ramipril—Diarrhoea—Prednisone—prostate cancer	4.87e-05	0.000146	CcSEcCtD
Ramipril—Decreased appetite—Epirubicin—prostate cancer	4.83e-05	0.000145	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—prostate cancer	4.81e-05	0.000144	CcSEcCtD
Ramipril—Gastrointestinal disorder—Epirubicin—prostate cancer	4.8e-05	0.000144	CcSEcCtD
Ramipril—Fatigue—Epirubicin—prostate cancer	4.8e-05	0.000144	CcSEcCtD
Ramipril—Constipation—Epirubicin—prostate cancer	4.76e-05	0.000143	CcSEcCtD
Ramipril—Nausea—Capecitabine—prostate cancer	4.74e-05	0.000142	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—MMP2—prostate cancer	4.71e-05	0.000824	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	4.71e-05	0.000824	CbGpPWpGaD
Ramipril—Dizziness—Prednisone—prostate cancer	4.7e-05	0.000141	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.69e-05	0.000141	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—prostate cancer	4.65e-05	0.00014	CcSEcCtD
Ramipril—BCHE—Metabolism—HPGD—prostate cancer	4.65e-05	0.000814	CbGpPWpGaD
Ramipril—BCHE—Metabolism—B4GALT4—prostate cancer	4.65e-05	0.000814	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGFBP3—prostate cancer	4.62e-05	0.000809	CbGpPWpGaD
Ramipril—Paraesthesia—Doxorubicin—prostate cancer	4.62e-05	0.000139	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—prostate cancer	4.59e-05	0.000138	CcSEcCtD
Ramipril—Feeling abnormal—Epirubicin—prostate cancer	4.58e-05	0.000138	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—prostate cancer	4.57e-05	0.000137	CcSEcCtD
Ramipril—Gastrointestinal pain—Epirubicin—prostate cancer	4.55e-05	0.000137	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—prostate cancer	4.53e-05	0.000136	CcSEcCtD
Ramipril—Vomiting—Prednisone—prostate cancer	4.52e-05	0.000136	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—ACHE—prostate cancer	4.51e-05	0.00079	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—MDM2—prostate cancer	4.49e-05	0.000786	CbGpPWpGaD
Ramipril—Rash—Prednisone—prostate cancer	4.48e-05	0.000135	CcSEcCtD
Ramipril—Dermatitis—Prednisone—prostate cancer	4.48e-05	0.000135	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—prostate cancer	4.47e-05	0.000134	CcSEcCtD
Ramipril—Headache—Prednisone—prostate cancer	4.45e-05	0.000134	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.44e-05	0.000133	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—prostate cancer	4.44e-05	0.000133	CcSEcCtD
Ramipril—Urticaria—Epirubicin—prostate cancer	4.42e-05	0.000133	CcSEcCtD
Ramipril—Constipation—Doxorubicin—prostate cancer	4.4e-05	0.000132	CcSEcCtD
Ramipril—Body temperature increased—Epirubicin—prostate cancer	4.4e-05	0.000132	CcSEcCtD
Ramipril—Abdominal pain—Epirubicin—prostate cancer	4.4e-05	0.000132	CcSEcCtD
Ramipril—BCHE—Metabolism—TNFRSF21—prostate cancer	4.37e-05	0.000766	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—RPS19—prostate cancer	4.34e-05	0.000759	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CTSD—prostate cancer	4.27e-05	0.000747	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	4.26e-05	0.000746	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MTAP—prostate cancer	4.26e-05	0.000745	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP7B1—prostate cancer	4.26e-05	0.000745	CbGpPWpGaD
Ramipril—Feeling abnormal—Doxorubicin—prostate cancer	4.24e-05	0.000127	CcSEcCtD
Ramipril—Nausea—Prednisone—prostate cancer	4.22e-05	0.000127	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—prostate cancer	4.21e-05	0.000126	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—THBS1—prostate cancer	4.21e-05	0.000736	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	4.16e-05	0.000728	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SULT1E1—prostate cancer	4.15e-05	0.000726	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SRD5A1—prostate cancer	4.15e-05	0.000726	CbGpPWpGaD
Ramipril—Hypersensitivity—Epirubicin—prostate cancer	4.1e-05	0.000123	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—prostate cancer	4.09e-05	0.000123	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—prostate cancer	4.07e-05	0.000122	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—prostate cancer	4.07e-05	0.000122	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	4.03e-05	0.000705	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CALR—prostate cancer	4e-05	0.0007	CbGpPWpGaD
Ramipril—Asthenia—Epirubicin—prostate cancer	3.99e-05	0.00012	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	3.97e-05	0.000694	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ACSL4—prostate cancer	3.96e-05	0.000692	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD17B3—prostate cancer	3.96e-05	0.000692	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.96e-05	0.000692	CbGpPWpGaD
Ramipril—Pruritus—Epirubicin—prostate cancer	3.93e-05	0.000118	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—CXCL8—prostate cancer	3.91e-05	0.000685	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	3.91e-05	0.000684	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ACE—prostate cancer	3.81e-05	0.000666	CbGpPWpGaD
Ramipril—Diarrhoea—Epirubicin—prostate cancer	3.81e-05	0.000114	CcSEcCtD
Ramipril—BCHE—Metabolism—PHGDH—prostate cancer	3.79e-05	0.000664	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ARG2—prostate cancer	3.79e-05	0.000664	CbGpPWpGaD
Ramipril—BCHE—Metabolism—UMPS—prostate cancer	3.79e-05	0.000664	CbGpPWpGaD
Ramipril—Hypersensitivity—Doxorubicin—prostate cancer	3.79e-05	0.000114	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	3.77e-05	0.000661	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LDHB—prostate cancer	3.72e-05	0.000651	CbGpPWpGaD
Ramipril—Asthenia—Doxorubicin—prostate cancer	3.69e-05	0.000111	CcSEcCtD
Ramipril—Dizziness—Epirubicin—prostate cancer	3.68e-05	0.00011	CcSEcCtD
Ramipril—BCHE—Metabolism—CYP3A5—prostate cancer	3.65e-05	0.000639	CbGpPWpGaD
Ramipril—Pruritus—Doxorubicin—prostate cancer	3.64e-05	0.000109	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—CTNNB1—prostate cancer	3.61e-05	0.000632	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PIK3CA—prostate cancer	3.58e-05	0.000627	CbGpPWpGaD
Ramipril—Vomiting—Epirubicin—prostate cancer	3.54e-05	0.000106	CcSEcCtD
Ramipril—BCHE—Metabolism—PDHA1—prostate cancer	3.53e-05	0.000617	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTA3—prostate cancer	3.53e-05	0.000617	CbGpPWpGaD
Ramipril—BCHE—Metabolism—UCP3—prostate cancer	3.53e-05	0.000617	CbGpPWpGaD
Ramipril—BCHE—Metabolism—TCN2—prostate cancer	3.53e-05	0.000617	CbGpPWpGaD
Ramipril—Diarrhoea—Doxorubicin—prostate cancer	3.52e-05	0.000106	CcSEcCtD
Ramipril—Rash—Epirubicin—prostate cancer	3.51e-05	0.000105	CcSEcCtD
Ramipril—Dermatitis—Epirubicin—prostate cancer	3.5e-05	0.000105	CcSEcCtD
Ramipril—Headache—Epirubicin—prostate cancer	3.48e-05	0.000105	CcSEcCtD
Ramipril—BCHE—Neuronal System—MDM2—prostate cancer	3.44e-05	0.000602	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—PLAUR—prostate cancer	3.42e-05	0.000598	CbGpPWpGaD
Ramipril—Dizziness—Doxorubicin—prostate cancer	3.4e-05	0.000102	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.38e-05	0.000592	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC22A3—prostate cancer	3.36e-05	0.000589	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD3B1—prostate cancer	3.36e-05	0.000589	CbGpPWpGaD
Ramipril—Nausea—Epirubicin—prostate cancer	3.3e-05	9.92e-05	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—prostate cancer	3.27e-05	9.83e-05	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.26e-05	0.000571	CbGpPWpGaD
Ramipril—Rash—Doxorubicin—prostate cancer	3.24e-05	9.75e-05	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—prostate cancer	3.24e-05	9.74e-05	CcSEcCtD
Ramipril—BCHE—Metabolism—TBXAS1—prostate cancer	3.23e-05	0.000564	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTA4—prostate cancer	3.23e-05	0.000564	CbGpPWpGaD
Ramipril—Headache—Doxorubicin—prostate cancer	3.22e-05	9.68e-05	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.15e-05	0.000552	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTA2—prostate cancer	3.14e-05	0.00055	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.14e-05	0.00055	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ABCG5—prostate cancer	3.1e-05	0.000543	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SULT1A1—prostate cancer	3.1e-05	0.000543	CbGpPWpGaD
Ramipril—Nausea—Doxorubicin—prostate cancer	3.06e-05	9.18e-05	CcSEcCtD
Ramipril—BCHE—Metabolism—GSTA1—prostate cancer	3.03e-05	0.000531	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NAT2—prostate cancer	3e-05	0.000525	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD3B2—prostate cancer	3e-05	0.000525	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTO1—prostate cancer	3e-05	0.000525	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.88e-05	0.000505	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LRP2—prostate cancer	2.87e-05	0.000503	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP2C18—prostate cancer	2.87e-05	0.000503	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PLCB2—prostate cancer	2.87e-05	0.000503	CbGpPWpGaD
Ramipril—BCHE—Metabolism—P4HB—prostate cancer	2.82e-05	0.000493	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC22A1—prostate cancer	2.74e-05	0.00048	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.71e-05	0.000474	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SULT2A1—prostate cancer	2.67e-05	0.000468	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MED12—prostate cancer	2.63e-05	0.00046	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GNG5—prostate cancer	2.61e-05	0.000457	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NCOA3—prostate cancer	2.51e-05	0.00044	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.47e-05	0.000432	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HPGDS—prostate cancer	2.4e-05	0.00042	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP2C19—prostate cancer	2.38e-05	0.000417	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—LEP—prostate cancer	2.36e-05	0.000414	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTT1—prostate cancer	2.32e-05	0.000407	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ACHE—prostate cancer	2.32e-05	0.000407	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP2A6—prostate cancer	2.3e-05	0.000402	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.29e-05	0.000401	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AKR1C3—prostate cancer	2.24e-05	0.000391	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PRKACB—prostate cancer	2.22e-05	0.000389	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP17A1—prostate cancer	2.2e-05	0.000385	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.17e-05	0.00038	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NCOA2—prostate cancer	2.1e-05	0.000367	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—INS—prostate cancer	2.02e-05	0.000353	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC5A5—prostate cancer	2e-05	0.00035	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP2E1—prostate cancer	1.95e-05	0.000342	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGF1—prostate cancer	1.95e-05	0.000342	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NQO1—prostate cancer	1.93e-05	0.000338	CbGpPWpGaD
Ramipril—BCHE—Metabolism—TH—prostate cancer	1.9e-05	0.000333	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.89e-05	0.000331	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MMP2—prostate cancer	1.89e-05	0.000331	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP3A4—prostate cancer	1.88e-05	0.00033	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.87e-05	0.000328	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP1B1—prostate cancer	1.85e-05	0.000324	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GGT1—prostate cancer	1.79e-05	0.000314	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NCOA1—prostate cancer	1.77e-05	0.000309	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP19A1—prostate cancer	1.74e-05	0.000305	CbGpPWpGaD
Ramipril—BCHE—Metabolism—RXRA—prostate cancer	1.68e-05	0.000294	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.63e-05	0.000286	CbGpPWpGaD
Ramipril—BCHE—Metabolism—COMT—prostate cancer	1.62e-05	0.000283	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTP1—prostate cancer	1.61e-05	0.000282	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ITPR1—prostate cancer	1.59e-05	0.000278	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CXCL8—prostate cancer	1.57e-05	0.000275	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.56e-05	0.000273	CbGpPWpGaD
Ramipril—BCHE—Metabolism—TYMS—prostate cancer	1.5e-05	0.000262	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTM1—prostate cancer	1.48e-05	0.000259	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LPL—prostate cancer	1.45e-05	0.000254	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	1.45e-05	0.000254	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP1A1—prostate cancer	1.4e-05	0.000246	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ERCC2—prostate cancer	1.39e-05	0.000244	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MTHFR—prostate cancer	1.31e-05	0.000229	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPARA—prostate cancer	1.28e-05	0.000225	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CAV1—prostate cancer	1.21e-05	0.000211	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.15e-05	0.000202	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CG—prostate cancer	1.1e-05	0.000192	CbGpPWpGaD
Ramipril—BCHE—Metabolism—INS—prostate cancer	1.04e-05	0.000182	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CREBBP—prostate cancer	1.02e-05	0.000178	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CD—prostate cancer	9.67e-06	0.000169	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NOS3—prostate cancer	9.13e-06	0.00016	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CB—prostate cancer	8.43e-06	0.000147	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTGS2—prostate cancer	8.35e-06	0.000146	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTEN—prostate cancer	7.28e-06	0.000127	CbGpPWpGaD
Ramipril—BCHE—Metabolism—EP300—prostate cancer	6.94e-06	0.000122	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CA—prostate cancer	5.14e-06	8.99e-05	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AKT1—prostate cancer	4.2e-06	7.34e-05	CbGpPWpGaD
